glp-1 sparks More than a shot: Weight loss drugs are reshaping student health, identity GLP-1 therapies spark transformation in

Week one is protected weight-bearing in a surgical boot

The quest to turn injectable biologics into pills is not a new ambition

While semaglutide will remain a foundational therapy in the class, the markets center of gravity is shifting toward multi-agonist and combination-based innovations that deliver higher efficacy with comparable safety and durability

The most extensively engineered laccases for industrial applications are from white-rot fungi, which have been improved for activity in ionic liquids, high and low pH, high temperature and physiological fluids 26

Lorenzo Leggio, an addiction researcher at the National Institutes of Health, who was not involved in the study